NCT06540924

Brief Summary

Adolescent Idiopathic Scoliosis (AIS) is a common disease of the spine observed in individuals aged 10-18 who typically do not have any other health issues. Despite numerous genetic studies conducted across different ethnic groups worldwide, the specific genes contributing to the development of scoliosis have not yet been definitively identified. Therefore, the aim of our study is to investigate whether there is an etiological relationship between AIS and the polymorphisms of the LBX1 (rs11190870, rs625039, rs11598564), TIMP2 (rs8179090), GPR126 (rs6570507), and CHD7 (rs121434341) genes in the Turkish population and to determine the relationship of these polymorphisms with gender, age, age at diagnosis and Cobb angle in these patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
301

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 8, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 30, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 6, 2024

Completed
Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

July 30, 2024

Last Update Submit

August 7, 2024

Conditions

Keywords

Adolescent idiopathic scoliosisgeneticsingle nucleotide polymorphism

Outcome Measures

Primary Outcomes (1)

  • Investigation of LBX1, TIMP2, GPR126, and CHD7 Gene Polymorphisms in 201 Turkish Adolescents With Idiopathic Scoliosis

    Despite numerous genetic studies conducted across different ethnic groups worldwide, the specific genes contributing to the development of scoliosis have not yet been definitively identified. Therefore, the aim of investigator is to investigate whether there is an etiological relationship between adolescent idiopathic scoliosis and the polymorphisms of the LBX1 (rs11190870, rs625039, rs11598564), TIMP2 (rs8179090), GPR126 (rs6570507), and CHD7 (rs121434341) genes in the Turkish population.

    12 months

Study Arms (2)

Study group

Being diagnosed with Adolescent Idiopathic Scoliosis (AIS) between the ages of 10 and 18 group. Having a Cobb angle of 10 degrees or greater on a plain radiograph. Not having any known genetic disorders. Not having any diseases known to play a role in the etiology of scoliosis (degenerative, neuromuscular, congenital scoliosis, etc., are excluded).

Other: single nucleotide polymorphisms

Control group

Healthy individuals between the ages of 10-18 who do not have scoliosis by physical examination and/or imaging.

Other: single nucleotide polymorphisms

Interventions

The LBX1 (Ladybird Homeobox 1), TIMP2 (Tissue Inhibitor of Metalloprotease 2), GPR126 (G Protein-Coupled Receptor 126) and CHD7 (Chromodomain Helicase DNA Binding Protein 7) gene polymorphisms in adolescent idiopathic scoliosis patients and the control group were analyzed using real-time PCR with TaqMan probe SNP (single nucleotide polymorphism) primers (rs625039, rs11598564, rs6570507, rs121434341, rs11190870, rs8179090).

Control groupStudy group

Eligibility Criteria

Age10 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Individuals applying to Uludag University Orthopedics and Traumatology polyclinic.

You may qualify if:

  • Study group
  • Being diagnosed with Adolescent Idiopathic Scoliosis (AIS) between the ages of 10 and 18.
  • Having a Cobb angle of 10 degrees or greater on a plain radiograph.
  • Not having any known genetic disorders.
  • Not having any diseases known to play a role in the etiology of scoliosis (degenerative, neuromuscular, congenital scoliosis, etc., are excluded).
  • Control group
  • Healthy individuals who have not been diagnosed with scoliosis by physical examination and/or imaging.
  • Being between the ages of 10-18

You may not qualify if:

  • Study group
  • Those diagnosed with non-idiopathic scoliosis.
  • Individuals who develop scoliosis after the age of 18.
  • Individuals with scoliosis under the age of 10.
  • Those diagnosed with a genetic disease.
  • Those diagnosed with any disease known to play a role in the etiology of scoliosis.
  • Control group
  • Those who have physical examination suspicion of scoliosis.
  • Those with a Cobb angle of 10 degrees or more on plain radiographs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uludag University

Bursa, 16059, Turkey (Türkiye)

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples were collected from patients and control individuals using purple-capped EDTA tubes, with 2 tubes per person (totaling 6 cc). The samples were stored at -80°C until the DNA isolation process. DNA was isolated from the collected blood samples, followed by DNA quality assessment. Subsequently, analysis was conducted using primers for the SNP (single nucleotide polymorphism) regions under study on a Real-Time Polymerase Chain Reaction (RT-PCR) device.

MeSH Terms

Interventions

Polymorphism, Single Nucleotide

Intervention Hierarchy (Ancestors)

Polymorphism, GeneticGenetic VariationGenetic Phenomena

Study Officials

  • Erkan Bilgin, Doctor

    Uludag University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist medical doctor

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 6, 2024

Study Start

July 8, 2022

Primary Completion

December 8, 2022

Study Completion

July 8, 2023

Last Updated

August 9, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations